Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis

BACKGROUND: The weight loss benefit of semaglutide in patients with diabetes is well-documented, but its clinical utility in treating obesity among patients without diabetes is less described. We therefore assessed the efficacy and safety of subcutaneous semaglutide as treatment for obesity in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Hanna Clementine, Dampil, Oliver Allan, Marquez, Maricar Mae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the ASEAN Federation of Endocrine Societies 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758543/
https://www.ncbi.nlm.nih.gov/pubmed/36578889
http://dx.doi.org/10.15605/jafes.037.02.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758543/
https://www.ncbi.nlm.nih.gov/pubmed/36578889
http://dx.doi.org/10.15605/jafes.037.02.14

Ejemplares similares